|

Clopidogrel Clinical Trials

7 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: Clopidogrel Hydrogen Sulphate Tablets, Platless Tab., Plavix

Pipeline

Phase 2: 1Phase 3: 2Phase 4: 4

Top Sponsors

  • University of Florida2
  • St. Antonius Hospital1
  • Seoul National University Bundang Hospital1
  • Peking Union Medical College Hospital1
  • Jiangsu vcare pharmaceutical technology co., LTD1

Indications

  • Heart Disease6
  • Coronary Artery Disease3
  • Percutaneous Coronary Intervention2
  • Coagulation Factors1
  • Antiplatelet Therapy1

Other5 trials

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
Phase 4
Clopidogrel Versus Cilostazol on Vessels
Phase 4
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Phase 3
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
Phase 2
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Phase 3

Jacksonville, Florida2 trials

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

University of Florida Health

Phase 4
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

University of Florida Jacksonville

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.